Dermatology Documentation That Survives an Audit

Table of Contents

Five recurring charting failures—and the language that makes each claim defensible

THE BOTTOM LINE  Most dermatology denials do not begin with the code. They begin with a chart that never captured the fact the code depends on.

The pattern is remarkably consistent.

A lesion is treated but never measured. A procedure is documented, but its clinical purpose is unclear. An office visit is billed on the same day, yet the note does not show work beyond the usual assessment built into the procedure. A biopsy is followed by destruction or removal, but the record never explains when—or why—the treatment decision changed.

Each omission may look small in real time. Under review, however, it can become the reason a payer concludes that the selected code, modifier, or separate service was not supported. The solution is not longer notes. It is documentation that captures the few facts on which code selection and medical necessity actually turn.

1. Give every lesion a traceable identity

Dermatology notes often involve several lesions in a single encounter. If the record uses only phrases such as “lesion on arm” or “spot on face,” an auditor may be unable to match the diagnosis, biopsy, destruction, pathology result, and later definitive treatment to the same lesion.

For each lesion, document the exact anatomic site, laterality, size, morphology, clinical impression, symptoms or change, and the procedure performed. If several lesions are treated, label them consistently—Lesion A, B, and C or Site 1, 2, and 3—and carry those labels through the procedure note, specimen container, pathology order, and follow-up plan.

WEAK CHART“Suspicious lesion on arm. Shave biopsy performed.”
DEFENSIBLE CHART“Lesion A: left dorsal forearm, 7 x 6 mm erythematous hyperkeratotic papule, enlarging and tender. Differential diagnosis: SCC versus inflamed seborrheic keratosis. Tangential biopsy obtained and submitted as Specimen A.”
DENIAL RISKDocumentation does not support the billed service, lesion count, site, size, or medical necessity.
AUDIT-SAFE HABIT  Assign each lesion a unique label before documenting the assessment and plan. If an auditor cannot follow the lesion across the chart, pathology, and treatment, the claim is vulnerable.

2. State why each biopsy or destruction was performed

A procedure name is not a medical-necessity statement. The record should show what made the lesion clinically concerning or symptomatic and how the procedure answered a diagnostic question or treated a documented problem.

For a biopsy, connect the lesion’s features to the differential diagnosis and state that tissue was obtained to establish a diagnosis. For destruction, identify the lesion type and document the symptoms, clinical risk, failed conservative care when relevant, or other reason treatment was warranted. Avoid cloning the same generic rationale across every lesion.

WEAK CHART“Biopsy recommended. Risks discussed.”
DEFENSIBLE CHART“Because of recent growth, spontaneous bleeding, and irregular pigmentation, biopsy is medically necessary to distinguish melanoma from an atypical nevus. The result will determine excision margins and follow-up.”
DENIAL RISKMedical necessity not established; procedure appears screening, cosmetic, or unsupported by the recorded findings.

3. Make modifier 25 visible in the note—not just on the claim

The decision to perform a minor procedure includes the usual pre-service evaluation, explanation, consent, and routine post-service instructions. Those activities alone do not support a separate E/M service. Modifier 25 applies only when the same-day E/M work is significant and separately identifiable beyond the work inherent in the procedure.

The note should make the additional cognitive work easy to see: a separately evaluated problem, a meaningful change in treatment, medication management, review of relevant data, or a broader assessment that would have been performed even if the procedure had not occurred. A different diagnosis is not required, but the distinct work is.

WEAK CHART“Patient evaluated. Lesion biopsied. Return when results are available.”
DEFENSIBLE CHART“In addition to evaluation and biopsy of Lesion A, worsening atopic dermatitis involving approximately 12% BSA was assessed. Prior treatment response and adverse effects were reviewed; topical regimen was changed and systemic therapy options were discussed.”
DENIAL RISKThe E/M service is included in the procedure allowance because a significant, separately identifiable service was not supported.
QUICK TEST  Remove the procedure from the encounter. Does the remaining documentation still support a medically necessary E/M service at the reported level? If not, modifier 25 is difficult to defend.

4. Align each modifier with the fact it is meant to communicate

Modifiers do not create separate payment; they explain a circumstance already documented in the record. Modifier 25 belongs on the E/M code. Modifier 59—or a more specific X modifier when accepted—belongs on a non-E/M service only when the service is truly distinct and a code-pair edit would otherwise bundle it. Laterality, repeat-procedure, postoperative, and assistant-surgery modifiers each require their own supporting facts.

Before adding a modifier, identify the exact sentence in the chart that supports it. If the sentence is missing, do not rely on the modifier to fill the gap. Correct the documentation prospectively or obtain a compliant clarification when appropriate.

WEAK CHARTModifier 59 added automatically whenever two procedures appear on the same claim.
DEFENSIBLE CHART“Lesion A on the right cheek was biopsied for diagnosis. Separate Lesion B on the left forearm, previously diagnosed as actinic keratosis, was destroyed.” The claim modifier reflects separate lesions and distinct purposes.
DENIAL RISKProcedure is incidental or included in another service; modifier is missing, invalid, or inconsistent with the procedure.

5. Build a clear bridge from biopsy to definitive removal

Biopsy and definitive removal of the same lesion are not automatically separately reportable on the same date. The chart must distinguish a true diagnostic biopsy—performed before the diagnosis or treatment decision was established—from tissue sampling that is simply part of the definitive procedure.

When both services occur on the same day, document the sequence: what was uncertain, why the biopsy was necessary, when the result became available, and how that result led to the decision for excision, destruction, or another definitive treatment. If the treatment plan was already established before the sample was taken, separate biopsy reporting is generally difficult to support.

WEAK CHART“Biopsy and destruction performed on the same lesion.”
DEFENSIBLE CHART“The lesion’s diagnosis was uncertain at presentation. A diagnostic biopsy was performed first. After rapid pathology confirmed [diagnosis], the findings and treatment options were reviewed and the decision was made to proceed with definitive treatment during the same encounter.”
DENIAL RISKBiopsy is considered integral to the definitive procedure because a separate diagnostic purpose and subsequent treatment decision were not demonstrated.

The same-day documentation checklist

Before closing the encounter, confirm that the record answers each of these questions:

  • Can every lesion be matched to a precise site, laterality, measurement, assessment, procedure, specimen, and plan?
  • Does the note explain why each biopsy, destruction, excision, injection, or repair was medically necessary?
  • If an E/M service is billed with a procedure, is the work beyond the usual procedure-related assessment clearly identifiable?
  • Does every modifier correspond to a documented fact—and is it attached to the correct code?
  • If biopsy and definitive treatment occurred on the same lesion, does the chart show a genuine diagnostic step followed by a new treatment decision?
  • Do procedure counts, lesion counts, sizes, locations, pathology labels, and diagnosis links agree across the entire claim?

Small language changes, stronger claims

Audit-defensible documentation is not documentation written for an auditor. It is a clinically coherent record that allows another reader to understand what was found, why action was taken, what work was distinct, and how the claim follows from the care delivered.

The highest-value improvement is simple: stop treating lesion details, procedure rationale, and modifier support as separate coding tasks completed after the visit. Capture them as part of the clinical story while the encounter is happening. That is how a chart moves from technically complete to defensible.

Common denial language these habits help prevent

Documentation gapCommon denial or audit conclusion
Missing lesion site, size, or countThe medical record does not support the code, units, anatomical site, or medical necessity reported.
Weak same-day E/M rationaleThe E/M service is included in the allowance for the procedure; a significant, separately identifiable service was not demonstrated.
Unsupported or misplaced modifierThe modifier is missing, invalid, or inconsistent with the procedure or documentation.
Unclear biopsy-to-treatment sequenceThe biopsy is integral to the definitive service because a distinct diagnostic purpose was not established.

Note: Actual denial codes and wording vary by payer and claim circumstance. Use the applicable payer policy, remittance advice, NCCI edits, and current CPT guidance for claim-specific decisions.

References

  • Centers for Medicare & Medicaid Services. Medicare NCCI Policy Manual, Chapter 3: Surgery—Integumentary System (2026).
  • Centers for Medicare & Medicaid Services. Guidance on modifier 25 and significant, separately identifiable E/M services.
  • American Academy of Dermatology. Coding Resource Center.
  • Applicable Medicare Administrative Contractor LCDs and Billing and Coding Articles; individual commercial payer medical and reimbursement policies.

Educational notice: This article provides general documentation and coding education. It does not replace the current CPT code set, payer policy, legal advice, or review of the complete medical record for a specific claim.

Table of Contents

Share on:
Scroll to Top